Awake intubation through an intubating laryngeal airway (ILATM) in a patient with Still’s disease
- 367 Downloads
To the Editor:
The intubating laryngeal airway (ILATM) (Mercury Medical, Clearwater, FL, USA) is a new supraglottic airway with an insertion technique and functionality very similar to the FastrachTM laryngeal mask airway (LMA-FastrachTM). We describe the use of the ILATM in fibreoptic-guided intubation in a patient with Still’s disease and an anticipated difficult airway. Written consent was obtained from the patient for publication of this article.
Still’s disease is characterized by fever, skin rash, myalgia, polyarthritis, limited cervical spine extension, atlanto-axial subluxation, temporomandibular joint involvement, and a potentially difficult airway.1 The adult form of the disease has an estimated incidence of 0.16 cases/100,000 persons/year.1 Our patient had a 12-mm mouth opening, cervical immobility, and an anticipated difficult airway.
Recent practice guidelines of the American Society of Anesthesiologists, the Canadian Airway Focus Group, and the Difficult Airway Society recommend the use of alternative airway devices, including the LMA-FastrachTM, in the management of patients with anticipated and unanticipated difficult airways. There is a higher success rate with bronchoscope-guided intubation compared with blind intubation through the LMA-FastrachTM,2 and the ILATM, a new supraglottic airway device first introduced for North American clinical use in 2004, has been recommended as an alternative device for tracheal intubation.3,4 Unlike the LMA-FastrachTM, the ILATM does not have a metal handle or metal shaft; it is inserted like a LMA-ClassicTM, and larger diameter tracheal tubes can be used.3 With an anterior-posterior diameter of 28 mm, the junction of the metallic shaft and bowl of the LMA-FastrachTM is not compressible. In contrast, with an anterior-posterior diameter of 15 mm, the junction of the shaft and bowl of the ILATM is compressible. Therefore, the ILATM could be inserted successfully into the oral cavity of our patient with a mouth opening of 12 mm, whereas the LMA-FastrachTM could not be inserted.
There are several advantages of the ILATM vs the LMA-FastrachTM in tracheal intubation: The ILATM is relatively inexpensive; there is familiarity with the insertion technique due to similarities with the LMA-ClassicTM; it has a thin anterior-posterior profile; and regular tracheal tubes can be used. However, there are several limitations with supraglottic airway-guided intubation: Anatomical features of Still’s disease (limited mouth opening and cervical immobility) may prevent the use of supraglottic airways; although bronchoscope-guided tracheal intubations through supraglottic airway devices are associated with a higher success rate, passage of the tracheal tube is not universally successful.5
In summary, a patient with Still’s disease presented with limited mouth opening, cervical immobility, and an anticipated difficult airway. We describe awake insertion of a new supraglottic airway device, the ILATM, and successful bronchoscope-guided tracheal intubation through the ILATM. The described technique may be a useful alternative in patients with anticipated or unanticipated difficult airways.
Conflicts of interest